Citius Oncology, Inc.
CTOR
$0.70
$0.022.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.30M | 3.92M | 100.00 | 100.00 | 100.00 |
| Total Receivables | 4.05M | -- | -- | -- | -- |
| Inventory | 22.64M | 22.29M | 17.21M | 15.34M | 14.38M |
| Prepaid Expenses | 3.16M | 1.33M | 1.10M | 2.70M | 2.70M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 37.15M | 27.54M | 18.31M | 18.04M | 17.08M |
|
|
|||||
| Total Current Assets | 37.15M | 27.54M | 18.31M | 18.04M | 17.08M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 72.83M | 73.40M | 73.40M | 73.40M | 73.40M |
| Total Assets | 109.97M | 100.94M | 91.71M | 91.44M | 90.48M |
|
|
|||||
| Total Accounts Payable | 10.45M | 13.23M | 8.67M | 7.68M | 5.87M |
| Total Accrued Expenses | 16.01M | 13.61M | 15.92M | 13.66M | 9.12M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 18.25M | 22.65M | 28.40M | 28.40M | 28.40M |
| Total Other Current Liabilities | 18.25M | 22.65M | 28.40M | 28.40M | 28.40M |
| Total Current Liabilities | 44.71M | 49.49M | 52.99M | 49.74M | 43.40M |
|
|
|||||
| Total Current Liabilities | 44.71M | 49.49M | 52.99M | 49.74M | 43.40M |
| Long-Term Debt | 3.80M | 3.80M | 3.80M | 3.80M | 3.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.05M | 2.79M | 2.52M | 2.26M | 1.99M |
| Total Liabilities | 51.56M | 56.08M | 59.31M | 55.80M | 49.19M |
|
|
|||||
| Common Stock & APIC | 127.99M | 108.91M | 91.44M | 89.32M | 87.23M |
| Retained Earnings | -69.57M | -64.04M | -59.04M | -53.67M | -45.94M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 58.41M | 44.87M | 32.40M | 35.64M | 41.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 58.41M | 44.87M | 32.40M | 35.64M | 41.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 58.41M | 44.87M | 32.40M | 35.64M | 41.29M |
|
|
|||||